Columbia Care Inc. CCHWF
We take great care to ensure that the data presented and summarized in this overview for Columbia Care Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CCHWF
View allLatest Institutional Activity in CCHWF
Top Purchases
Top Sells
About CCHWF
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Insider Transactions at CCHWF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2024
|
Julie A Hill |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+37.62%
|
-
|
|
Jun 26
2024
|
James A C Kennedy |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+11.49%
|
-
|
|
Jun 26
2024
|
Jeff Clarke |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+21.75%
|
-
|
|
Jun 26
2024
|
Alison Worthington |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+39.47%
|
-
|
|
Jun 26
2024
|
Frank Savage |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+35.68%
|
-
|
|
Jun 26
2024
|
Jonathan P May |
BUY
Exercise of conversion of derivative security
|
Direct |
309,091
+36.07%
|
-
|
|
May 01
2024
|
David Sirolly Chief Legal Officer/GC |
BUY
Exercise of conversion of derivative security
|
Direct |
18,086
+1.84%
|
-
|
|
Apr 23
2024
|
David Sirolly Chief Legal Officer/GC |
BUY
Grant, award, or other acquisition
|
Direct |
37,535
+3.82%
|
-
|
|
Apr 23
2024
|
Nicholas Vita |
BUY
Grant, award, or other acquisition
|
Direct |
177,771
+11.73%
|
-
|
|
Apr 23
2024
|
Jesse Channon President |
BUY
Grant, award, or other acquisition
|
Direct |
53,871
+2.82%
|
-
|
|
Apr 23
2024
|
David James Hart Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,805
+2.59%
|
-
|
|
Apr 23
2024
|
Rosemary Mazanet |
BUY
Grant, award, or other acquisition
|
Direct |
37,710
+1.72%
|
-
|
|
Apr 23
2024
|
Bryan Olson Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,871
+3.52%
|
-
|
|
Apr 05
2024
|
David Sirolly Chief Legal Officer/GC |
BUY
Exercise of conversion of derivative security
|
Direct |
545,454
+37.51%
|
-
|
|
Apr 05
2024
|
Bryan Olson Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
727,272
+33.83%
|
-
|
|
Apr 05
2024
|
Rosemary Mazanet |
BUY
Exercise of conversion of derivative security
|
Direct |
363,636
+14.66%
|
-
|
|
Apr 05
2024
|
Jesse Channon President |
BUY
Exercise of conversion of derivative security
|
Direct |
727,272
+28.77%
|
-
|
|
Apr 05
2024
|
Derek Watson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
727,272
+40.63%
|
-
|
|
Apr 05
2024
|
David James Hart Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090,909
+26.98%
|
-
|
|
Mar 31
2024
|
Nicholas Vita |
BUY
Exercise of conversion of derivative security
|
Direct |
455,809
+28.2%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 442K shares |
|---|---|
| Exercise of conversion of derivative security | 9.9M shares |
| Open market or private purchase | 279K shares |
| Open market or private sale | 91.8K shares |
| Open market or private sale | 3.33M shares |
|---|---|
| Payment of exercise price or tax liability | 37.6K shares |
| Bona fide gift | 2.8M shares |